Year: 2025
Type: article
Abstract: Semaglutide is one of the most widely used glucagon-like peptide-1 receptor agonists, initially approved for the treatment of type 2 diabetes and now increasingly utilized for obesity treatment. Its efficacy in weight reduction has led to a surge in popularity; however, concerns regarding its safety profile and potential side effects have emerged. This review aims to analyze the mechanism of action, therapeutic efficacy, and potential risks associated with semaglutide use.
Institution: University of Rzeszów
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $100
OpenAlex ID: W4414320876